Search Results 291-300 of 17047 for monoclonal antibody

  1. Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma - Mayo Clinic

    Monoclonal antibodies, such as anetumab ... Patients who have received any monoclonal antibody therapy within 4 weeks prior to entering the study.

  2. Eosinophilic esophagitis - Diagnosis and treatment - Mayo Clinic

    Monoclonal antibodies. The Food and Drug Administration (FDA) recently ... Dupilumab is a type of medicine known as a monoclonal antibody. It works to ...

  3. Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis - Mayo Clinic

    Monoclonal antibodies, such as isatuximab, may ... Patients must not have any known allergies to isatuximab or other monoclonal antibody therapies.

  4. Belantamab mafodotin-blmf (intravenous route) - Side effects & uses - Mayo Clinic

    ... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. This medicine is available only under a restricted ...

  5. Trastuzumab-dkst (intravenous route) - Mayo Clinic

    Trastuzumab-dkst is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

  6. Alzheimer's drug lecanemab granted full approval by FDA, Mayo Clinic expert weighs in

    A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...

  7. Radiation Therapy, Paclitaxel, and Carboplatin with or without Trastuzumab in Treating Patients with Esophageal Cancer - Mayo Clinic

    Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. ... monoclonal antibody; Previous history of congestive heart failure ...

  8. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    RO7790121 is a fully human immunoglobulin G1 monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A plays a central role in the ...

  9. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

    Imiquimod may stimulate the immune system. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

  10. Glioma Clinical Trials - Mayo Clinic Research

    A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response ( ...